Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of rapid optimized flow cytometry crossmatch (Halifaster) in living donor kidney transplantation.

HLA - 1 Feb 2024

Ramalhete Luis, Araújo Rúben, Teixeira Cristiana, Teixeira Ana, Almeida Paula, Silva Isabel, Lima Alice

Abstract excerpt

Kidney transplantation is often the preferred treatment for end-stage renal disease. However, the presence of preformed donor-specific antibodies (DSA), including those against HLA, can lead to antibody-mediated rejection and significantly impact transplant outcomes. The Flow Cytometry Crossmatch (FCXM) is a crucial tool in kidney transplantation, as it also enables the measurement of low levels of anti-HLA DSA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Antibodies
Share to Flow Cytometry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histocompatibility Testing

Share to Kidney Transplantation

Share to Living Donors

Source

Identifiers

PMID: 38372638
DOI: 10.1111/tan.15391

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of rapid optimized flow cytometry crossmatch (Halifaster) in living donor kidney transplantation.PMID 38372638Read ↗

Determination of unacceptable HLA antigen mismatches in kidney transplant recipients.Semantic proximity Read ↗

Evaluation of de novo donor specific antibodies after kidney transplantation in the era of donor-derived cell-free DNASemantic proximity Read ↗

Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allograftsSemantic proximity Read ↗

Persistently Elevated Donor-Derived Cell-Free DNA After Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Preliminary Observational StudySemantic proximity Read ↗

Clinical Applicability of 2-Field High-Resolution and Extended HLA-Allele Typing in Deceased Donor Kidney Allocation.Semantic proximity Read ↗

The evolution and clinical impact of Human Leukocyte Antigen technologySemantic proximity Read ↗

Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury.Semantic proximity Read ↗

Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for ImmunogeneticsSemantic proximity Read ↗

High-resolution multiplexed antibody-omics and interpretable machine learning unveil novel pathogenic mechanisms in kidney transplant rejectionSemantic proximity Read ↗

Molecular diagnosis of kidney allograft rejection based on the Banff Human Organ Transplant gene panel: A multicenter international studySemantic proximity Read ↗

HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunitySemantic proximity Read ↗

Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection MonitoringSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.